Veracyte (VCYT) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- S&P 500 ends higher as traders shift from AI to healthcare
- Caterpillar names Derrick York to lead Resource Industries
- Intel shares drop on foundry risks, sector pressures
Veracyte (VCYT) PT Lowered to $11 at Leerink Partners
March 20, 2015 7:57 AM EDTLeerink Partners analyst Dan Leonard maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT) but lowered his price target to $11.00 (from $14.00) following Q4 results.
Leonard commented, "VCYT's revenue for 4Q exceeded the Street and our expectations. While test volume growth is... More



